Anticoagulation application of nafamostat mesylate in patients on continuous renal replacement therapy at a high risk of hemorrhage
ObjectiveTo explore the efficacy and safety of nafamostat mesylate (NM) in patients on continuous renal replacement therapy (CRRT) at a high risk of hemorrhage.MethodsFrom March 2021 to February 2022, a retrospective study was conducted for 61 CRRT patients at a high risk of hemorrhage in intensive...
| Main Authors: | , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | zho |
| 出版: |
Editorial Department of Journal of Clinical Nephrology
2024-02-01
|
| 丛编: | Linchuang shenzangbing zazhi |
| 主题: | |
| 在线阅读: | http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2024.02.002 |